- Home
- AAME vs CASI Comparison
AAME vs CASI Comparison
Compare AAME & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAME
- CASI
- Stock Information
- Founded
- AAME 1968
- CASI 1991
- Country
- AAME United States
- CASI China
- Employees
- AAME N/A
- CASI N/A
- Industry
- AAME Life Insurance
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- AAME Finance
- CASI Health Care
- Exchange
- AAME Nasdaq
- CASI Nasdaq
- Market Cap
- AAME 27.1M
- CASI 31.0M
- IPO Year
- AAME N/A
- CASI 1996
- Fundamental
- Price
- AAME $1.81
- CASI $1.89
- Analyst Decision
- AAME
- CASI Strong Buy
- Analyst Count
- AAME 0
- CASI 1
- Target Price
- AAME N/A
- CASI $4.00
- AVG Volume (30 Days)
- AAME 20.0K
- CASI 8.4K
- Earning Date
- AAME 05-20-2025
- CASI 05-20-2025
- Dividend Yield
- AAME 1.10%
- CASI N/A
- EPS Growth
- AAME N/A
- CASI N/A
- EPS
- AAME N/A
- CASI N/A
- Revenue
- AAME $188,227,000.00
- CASI $28,537,000.00
- Revenue This Year
- AAME N/A
- CASI N/A
- Revenue Next Year
- AAME N/A
- CASI N/A
- P/E Ratio
- AAME N/A
- CASI N/A
- Revenue Growth
- AAME 0.77
- CASI N/A
- 52 Week Low
- AAME $1.25
- CASI $1.64
- 52 Week High
- AAME $1.99
- CASI $7.67
- Technical
- Relative Strength Index (RSI)
- AAME 69.34
- CASI 44.54
- Support Level
- AAME $1.52
- CASI $1.64
- Resistance Level
- AAME $1.60
- CASI $1.94
- Average True Range (ATR)
- AAME 0.12
- CASI 0.09
- MACD
- AAME 0.04
- CASI -0.00
- Stochastic Oscillator
- AAME 88.82
- CASI 55.77
About AAME Atlantic American Corporation
Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.